(Q43036202)

12 November 2017

title

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

Kanazawa Y

1

1 reference

12 November 2017

Hayashi N

2

1 reference

12 November 2017

Mita E

3

1 reference

12 November 2017

Li T

4

1 reference

12 November 2017

Hagiwara H

5

1 reference

12 November 2017

Kasahara A

6

1 reference

12 November 2017

Fusamoto H

7

1 reference

12 November 2017

Kamada T

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

12 November 2017

1 reference

12 November 2017

volume

20

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

1121-1130

1 reference

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Rapid evolution of RNA viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Hypervariable regions in the putative glycoprotein of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Marked sequence diversity in the putative envelope proteins of hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Structure and organization of the hepatitis C virus genome isolated from human carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Antigenic Diversity Thresholds and the Development of AIDS

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Mathematical model for studying genetic variation in terms of restriction endonucleases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Estimation of average number of nucleotide substitutions when the rate of substitution varies with nucleotide.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Molecular Evolutionary Genetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Allelic forms of rat κ chain genes: Evidence for strong selection at the level of nucleotide sequence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Resolution of acute hepatitis C after therapy with natural beta interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200504

7 January 2021

Identifiers

DOI

10.1002/HEP.1840200504

1 reference

12 November 2017

1 reference